Literature DB >> 24846508

Lamin A/C mutations in dilated cardiomyopathy.

Frédérique Tesson1, Michal Saj, Musfira Mohamed Uvaize, Hannah Nicolas, Rafał Płoski, Zofia Bilińska.   

Abstract

Dilated cardiomyopathy (DCM) is one of the leading causes of heart failure and heart transplant. Mutations in 60 genes have been associated with DCM. Approximately 6% of all DCM cases are caused by mutations in the lamin A/C gene (LMNA). LMNA codes for type-V intermediate filaments that support the structure of the nuclear membrane and are involved in chromatin structure and gene expression. Most LMNA mutations result in striated muscle diseases while the rest affects the adipose tissue, peripheral nervous system, multiple tissues or lead to progeroid syndromes/overlapping syndromes. Patients with LMNA mutations exhibit a variety of cellular and physiological phenotypes. This paper explores the current phenotypes observed in LMNA-caused DCM, the results and implications of the cellular and animal models of DCM and the prevailing theories on the pathogenesis of laminopathies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24846508     DOI: 10.5603/CJ.a2014.0037

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  22 in total

Review 1.  Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies.

Authors:  Babken Asatryan; Argelia Medeiros-Domingo
Journal:  J Mol Med (Berl)       Date:  2018-08-20       Impact factor: 4.599

2.  Heterozygous LMNA mutation-carrying iPSC lines from three cardiac laminopathy patients.

Authors:  Sangkyun Cho; Chelsea Lee; Celine Lai; Yan Zhuge; Francois Haddad; Michael Fowler; Karim Sallam; Joseph C Wu
Journal:  Stem Cell Res       Date:  2022-01-03       Impact factor: 1.587

Review 3.  Genetics of Dilated Cardiomyopathy.

Authors:  Yiwen Fu; Howard J Eisen
Journal:  Curr Cardiol Rep       Date:  2018-09-27       Impact factor: 2.931

Review 4.  Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair.

Authors:  Suya Wang; Jianshi Yu; Maureen A Kane; Alexander R Moise
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

5.  Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy.

Authors:  Nazish Sayed; Chun Liu; Mohamed Ameen; Farhan Himmati; Joe Z Zhang; Saereh Khanamiri; Jan-Renier Moonen; Alexa Wnorowski; Linling Cheng; June-Wha Rhee; Sadhana Gaddam; Kevin C Wang; Karim Sallam; Jack H Boyd; Y Joseph Woo; Marlene Rabinovitch; Joseph C Wu
Journal:  Sci Transl Med       Date:  2020-07-29       Impact factor: 17.956

6.  Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.

Authors:  Cinzia Forleo; Monica Carmosino; Nicoletta Resta; Alessandra Rampazzo; Rosanna Valecce; Sandro Sorrentino; Massimo Iacoviello; Francesco Pisani; Giuseppe Procino; Andrea Gerbino; Arnaldo Scardapane; Cristiano Simone; Martina Calore; Silvia Torretta; Maria Svelto; Stefano Favale
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

Review 7.  A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies.

Authors:  Marta Gigli; Rene L Begay; Gaetano Morea; Sharon L Graw; Gianfranco Sinagra; Matthew R G Taylor; Henk Granzier; Luisa Mestroni
Journal:  Front Cardiovasc Med       Date:  2016-07-21

Review 8.  Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy.

Authors:  Yee-Ki Lee; Yu Jiang; Xin-Ru Ran; Yee-Man Lau; Kwong-Man Ng; Wing-Hon Kevin Lai; Chung-Wah Siu; Hung-Fat Tse
Journal:  Stem Cell Res Ther       Date:  2016-09-20       Impact factor: 6.832

9.  LMNA Sequences of 60,706 Unrelated Individuals Reveal 132 Novel Missense Variants in A-Type Lamins and Suggest a Link between Variant p.G602S and Type 2 Diabetes.

Authors:  Alyssa Florwick; Tejas Dharmaraj; Julie Jurgens; David Valle; Katherine L Wilson
Journal:  Front Genet       Date:  2017-06-15       Impact factor: 4.599

Review 10.  Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development.

Authors:  Xiying Lin; Jiayu Tang; Yan-Ru Lou
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.